Harnessing mRNA technology to tackle unmet medical needs in Asia

Asia is emerging as a hub for biopharmaceuticals and vaccine manufacturing, leveraging its strengths in manufacturing an...

January 21, 2025 | Tuesday | Opinion
UQ and Vaxxas in Australia win $2 M from US to advance patch-based mRNA COVID-19 vaccine

Australia-based University of Queensland’s (UQ) BASE facility, within the Australian Institute for Bioenginee...

January 14, 2025 | Tuesday | News
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa

In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an I...

January 6, 2025 | Monday | News
SK bioscience inks KRW 75.5 B deal with Sanofi to develop next-gen pneumococcal conjugate vaccines

South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreem...

December 23, 2024 | Monday | News
Building vaccine and therapeutics manufacturing capacity in Asia Pacific

Scientists from Australia's Biomedical Manufacturing Programme are partnering with Thailand and Malaysia to en...

December 20, 2024 | Friday | News
Consortium set to further establish vaccine safety evidence-generation network in Africa

A research consortium is set to further establish a vaccine safety evidence-generation network in Africa, seeking to und...

December 17, 2024 | Tuesday | News
Korea's SK bioscience gets approval for global clinical trials of mRNA Japanese Encephalitis Vaccine candidate

South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from the Human R...

December 13, 2024 | Friday | News
Moderna officially opens new vaccine manufacturing facility in Australia

Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...

December 10, 2024 | Tuesday | News
Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children

American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...

December 3, 2024 | Tuesday | News
Sanofi introduces 'Modulus', world’s first modular manufacturing facility in Singapore

Sanofi announced the inauguration of its state-of-theart manufacturing facility, Modulus, in Singapore, on 27 Nov, marki...

November 27, 2024 | Wednesday | News
Korea-Africa partnership for advancing vaccine end-to-end capabilities

The Government of the Republic of Kenya and the International Vaccine Institute (IVI) in South Korea, have signed a Memo...

November 27, 2024 | Wednesday | News
Sanofi, A*STAR and NSC collaborate to advance Acne Vaccine R&D in Singapore

Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore (NSC) establish...

November 22, 2024 | Friday | News
Asia-Pacific Takes the Lead in Vaccine Innovations: Transforming Public Health with Prophylactic and Therapeutic Breakthroughs

Vaccines are the bedrock of public health, providing preventive solutions against infectious diseases while increasingly...

November 25, 2024 | Monday | Analysis
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan

Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...

November 18, 2024 | Monday | News
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH

Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...

October 29, 2024 | Tuesday | News
SK bioscience's Quadrivalent Influenza Vaccine SKYCellflu approved in Indonesia

SK bioscience, a global innovator in vaccines and biotechnology, announced that Indonesia's Food and Drug Agency, BPOM (...

October 23, 2024 | Wednesday | News
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding

The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...

October 13, 2024 | Sunday | News
China's CanSino receives over $17 M from Bill & Melinda Gates Foundation to accelerate polio vaccine development

China-based CanSino Biologics Inc. has received an additional financial boost, securing a grant exceeding $17 million to...

October 10, 2024 | Thursday | News